Table 1.
Isolates included in this studya
| Country | No. of isolates | ST | Yr(s) obtained | Origin(s) (no. of isolates) | Reference(s) |
|---|---|---|---|---|---|
| Portugal | 9 | 131 | 2001–2010 | H (6), F (1), E (2) | 21, Novais et al., submitted for publicationb |
| Spain | 6 | 131 | 1991–2008 | H (5), C (1) | 5, 25 |
| United Kingdom | 3 | 131 | ND | H (3) | 16 |
| United States of America | 3 | 131 | 2008 | A (3) | 14 |
| France | 3 | 131 | 2006 | F (3) | 18 |
| Norway | 2 | 131 | 2003 | H (2) | 23 |
| Czech Republic | 2 | 131 | 2006 | H (2) | 11 |
| South Korea | 2 | 131 | 2006–2007 | C (2) | 17 |
| Switzerland | 1 | 131 | 2005 | H (1) | 5 |
| Croatia | 1 | 1035 | 2005 | H (1) | 20 |
a
ST, sequence type; H, hospitalized humans (obtained from representative outbreaks); C, community-acquired infections (obtained from representative outbreaks); F, healthy humans (feces); A, animals (2 animal infections, 1 fecal isolate); E, environment (marine waters); ND, not determined.
b
Â. Novais, C. Rodrigues, R. Branquinho, P. Antunes, F. Grosso, L. Boaventura, G. Ribeiro, and L. Peixe, submitted for publication.